Retireful LLC’s West Pharmaceutical WST Stock Holding History

Retireful LLC’s Portfolio WST Stock Details WST Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-890	Closed	-$308K	–	126
2023 Q1	$308K	Buy	+890	New	+$260K	0.1%	54

Other funds holding WST

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

APG Asset Management Amsterdam, Netherlands $31.6B AUM 19.33% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCP

Durable Capital Partners Bethesda, Maryland $9.71B AUM 26.27% 1-Year Est. Return

Retireful LLC's WST Position: Q2 2023 in Review

Retireful LLC sold out of West Pharmaceutical (WST) in Q2 2023, closing a stake of 890 shares — an estimated $308K sold.

Retireful LLC first reported a position in WST in Q1 2023 and held it in 1 quarter. The position peaked at $308K in Q1 2023. 734 funds tracked by Wall St. Rank hold WST as of Q2 2023.

Retireful LLC reported no remaining West Pharmaceutical position as of Q2 2023 after selling out during the quarter.
Retireful LLC sold 890 West Pharmaceutical shares in Q2 2023, an estimated $308K.
Retireful LLC first reported a position in West Pharmaceutical in Q1 2023 and held it in 1 quarter.
Retireful LLC's West Pharmaceutical position peaked at $308K in Q1 2023.
734 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2023.

Based on Retireful LLC's 13F filing for Q2 2023, filed 11 Jul 2023.